Direct Genomics
Shenzhen
About Direct Genomics
Direct Genomics is making genomics an affordable part of everyday patient care. The company’s GenoCare instrument is the first single molecule sequencing system for clinical use. That simplifies sequencing by directly reading individual DNA and RNA molecule information from customer’s blood or tissue samples, delivering significant improvements in cost and speed. Established in 2012, Direct Genomics is headquartered in Shenzhen, China and backed by institutional and private investors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $34.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2018)
- Website: directgenomics.com
- Phone: +86 755 8671 4900
Industries & Categories
Biotechnology, Commercial
Social Profiles
Canonical: https://fsome.com/organization/direct-genomics-142330 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.